Neurology® Podcast
American Academy of Neurology
The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.
Episodes
Mentioned books
Feb 10, 2022 • 16min
Predicting Outcomes in GBS
Dr. Jeff Ratliff talks with Dr. Bart Jacobs about his study on the validity and region-specificity of the modified Erasmus GBS Outcome Score in predicting the risk of walking inability in patients with Guillain-Barré syndrome. Read the full article in Neurology.
Feb 7, 2022 • 25min
A Neurologist’s Personal Experience with DLB
Dr. Stacey Clardy interviews behavioral neurologist Dr. Daniel Drubach about his experience with being diagnosed with Lewy body dementia, highlighting the unique perspective his diagnosis has provided him as a physician and as a patient. Read Dr. Drubach's special article in Continuum: "Twilight and Me: A Soliloquy."
Feb 3, 2022 • 16min
Practice Guidelines for Painful Diabetic Neuropathy
Feb 1, 2022 • 42min
February 2022 Neurology Recall: Diagnosing and Treating Immune-Mediated Neuropathies
The February 2022 replay of past episodes showcases a selection of interviews regarding the diagnosis and treatment of immune-mediated neuropathies. This episode features Drs. Stacey Clardy and Ted Burns in conversation with Drs. Luise Appeltshauser, Shahar Shelly, and P. James B. Dyck, offering listeners essential insight into the identification and management of acute autoimmune neuropathy, chronic immune sensory polyradiculopathy, and lumbrosacral radiculoplexus neuropathy.
Jan 31, 2022 • 18min
Medicare Coverage of Aducanumab
Dr. Jason Crowell talks with Pulitzer Prize-winning New York Times journalist Pam Belluck about the impact of Medicare’s decision to limit patient access to aducanumab for the treatment of Alzheimer disease, restricting use to individuals in clinical trials.
Jan 27, 2022 • 36min
TikTok Tics?
Prof. Jon Stone talks with Dr. Tamara Pringsheim and Wall Street Journal columnist Julie Jargon about the increased incidence of teen girls presenting with physical tics and the potential association of exposure to TikTok videos on Tourette syndrome and functional neurologic disorder (FND).
Jan 25, 2022 • 14min
Navigating Aducanumab Decisions With Families: An AAN Position Statement
Dr. Jeff Ratliff talks with Dr. Winston Chiong about the new AAN Position Statement on ethical considerations in the use of aducanumab for patients with Alzheimer disease.
Jan 20, 2022 • 18min
Outcomes After Large Vessel Stroke Treated with Tenecteplase Before Thrombectomy
Dr. Dan Ackerman talks with Dr. Gaspard Gerschenfeld about the efficacy, safety, and outcomes of treating large vessel occlusion stroke with tenecteplase before thrombectomy.
Jan 17, 2022 • 16min
A Nationwide Cohort Study of Epilepsy-Related Death in Young People
Dr. Halley Alexander discusses the utility of a new systematic classification of epilepsy-related mortality used in a nationwide cohort study of children and young adults in Denmark with Dr. Marius Kløvgaard.
Jan 13, 2022 • 18min
The Amyloid Hypothesis for Alzheimer Disease and Aducanumab
Dr. Jeff Burns discusses the amyloid hypothesis and the challenges clinicians face in navigating discussions on the use of aducanumab for Alzheimer disease with Dr. Erik Musiek.
